Institutional investors purchased a net $773.7 thousand shares of EBS during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 79.92% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 276.8 Thousand shares of Emergent BioSolutions Inc